Sun Pharmaceuticals reported INR44.18B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Bharat Petroleum INR -40.55B 125.98B Jun/2026
Cipla INR 14.03B 4.48B Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
UPL INR 14.5B 21.08B Jun/2026